Global law firm Norton Rose Fulbright’s intellectual property practice has added partners Rhiannon D’Agostin and Adam Rehm as well as counsel Zack Cleary. It said this team of lawyers joins the firm’s patents practice from Polsinelli.
“Expanding Norton Rose Fulbright’s highly regarded IP practice is an important part of our firm’s strategic growth plan, and the addition of these elite lawyers affirms that commitment,” Jeff Cody, Norton Rose Fulbright’s U.S. Managing Partner, said in a statement. “These outstanding lawyers will complement our dynamic team, which provides clients with innovative and creative solutions that offer commercial value and further long-term priorities.”
Focus on patents and more
Rehm, who is located in Dallas, advises clients on patent and trademark prosecution, freedom to operate studies, licensing, and intellectual property litigation.
He is a registered U.S. patent attorney with more than 20 years of experience representing executives and research and development teams regarding intellectual property portfolio management, valuation, and development (including offensive and defensive patenting strategies), brand development strategies, and the implementation of university and corporate intellectual property standards. Rehm has represented some of the world’s largest manufacturers of electronic components and software. He works closely with doctors to identify and protect their intellectual property in a variety of areas, including medical devices and surgical implants, diagnostic and imaging equipment, telehealth systems, virtual/mixed reality surgical systems, and machine learning systems with predictive analytics.
Rehm began his career as a design engineer for a plastics engineering company and also served as a patent examiner at the USPTO.
“Lawyers in Norton Rose Fulbright’s top-notch intellectual property group serve some of the most forward-thinking companies in the world,” Rehm said. “The firm’s global platform and full-service capabilities are unmatched, and I look forward to leveraging my experience to further enhance its IP offering.”
From scientist to IP lawyer
D’Agostin, who is based in Denver, focuses on intellectual property counseling, including patent portfolio strategy and management, for both offensive and defensive considerations. She advises clients on a wide range of technologies such as biologics, diagnostics, medical devices, pharmaceuticals, cellular agriculture, and manufacturing processes and systems. Rhiannon’s practice encompasses intellectual property portfolio management, patent prosecution, proceedings before the U.S. Patent and Trademark Office, validity and infringement opinions, freedom to operate analysis, intellectual property due diligence, licensing and research agreements, Hatch-Waxman-related (pharmaceutical industry) issues, and patent litigation.
D’Agostin worked as a scientist for a large biologics company before beginning her legal career.
“I’m excited to join Norton Rose Fulbright because of the firm’s collegial culture and focus on IP law,” D’Agostin said. “The synergies between my practice and the firm’s intellectual property and patent groups make this an excellent fit for me.”
‘Innovation-focused approach’
The firm said that Cleary advises global technology leaders and startups in the development of comprehensive, strategy-driven patent portfolios in a variety of technology areas. His approach centers around his clients’ particular technological landscapes to help them build and enforce their intellectual property using utility patents, design patents, trademarks, and trade secrets.
“Adam, Rhiannon, and Zack are highly skilled IP lawyers with the kind of technical backgrounds and extensive subject matter knowledge that allows them to understand a client’s needs from the earliest stages of development. Their entrepreneurial and progressive practices fit well with our innovation-focused approach to providing clients with effective and efficient legal services,” Tim Kenny, Norton Rose Fulbright’s U.S. head of Intellectual Property, said in a statement.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.